X hits on this document

321 views

0 shares

0 downloads

0 comments

67 / 127

Medical: 5

Neurology: 3 ═══════════════════════════════════════════════════════════════════════════════════════ ═══════════════════════════

5-3.38 Define abscess. (C-1) 5-3.39 Recognize the signs and symptoms related to abscess. (C-1) 5-3.40 Correlate abnormal assessment findings with clinical significance in the patient with abscess. (C-3) 5-3.41 Differentiate among the various treatment and pharmacological interventions used in the management of

abscess. (C-3) 5-3.42 Integrate the pathophysiological principles and the assessment findings to formulate a field impression

and implement a treatment plan for the patient with abscess. (C-3) 5-3.43 Describe the epidemiology, including the morbidity/ mortality and prevention strategies, for stroke and

intracranial hemorrhage. (C-1) 5-3.44 Discuss the pathophysiology of stroke and intracranial hemorrhage. (C-1) 5-3.45 Describe the types of stroke and intracranial hemorrhage. (C-1) 5-3.46 Discuss the assessment findings associated with stroke and intracranial hemorrhage. (C-1) 5-3.47 Discuss the management/ treatment plan of stroke and intracranial hemorrhage. (C-1) 5-3.48 Define stroke and intracranial hemorrhage. (C-1) 5-3.49 Recognize the signs and symptoms related to stroke and intracranial hemorrhage. (C-1) 5-3.50 Correlate abnormal assessment findings with clinical significance in the patient with stroke and intracranial

hemorrhage. (C-3) 5-3.51 Differentiate among the various treatment and pharmacological interventions used in the management of

stroke and intracranial hemorrhage. (C-3) 5-3.52 Integrate the pathophysiological principles and the assessment findings to formulate a field impression

and implement a treatment plan for the patient with stroke and intracranial hemorrhage. (C-3) 5-3.53 Describe the epidemiology, including the morbidity/ mortality and prevention strategies, for transient

ischemic attack. (C-3) 5-3.54 Discuss the pathophysiology of transient ischemic attack. (C-1) 5-3.55 Discuss the assessment findings associated with transient ischemic attack. (C-1) 5-3.56 Discuss the management/ treatment plan of transient ischemic attack. (C-1) 5-3.57 Define transient ischemic attack. (C-1) 5-3.58 Recognize the signs and symptoms related to transient ischemic attack. (C-1) 5-3.59 Correlate abnormal assessment findings with clinical significance in the patient with transient ischemic

attack. (C-3) 5-3.60 Differentiate among the various treatment and pharmacological interventions used in the management of

transient ischemic attack. (C-3) 5-3.61 Integrate the pathophysiological principles and the assessment findings to formulate a field impression

and implement a treatment plan for the patient with transient ischemic attack. (C-3) 5-3.62 Describe the epidemiology, including the morbidity/ mortality and prevention strategies, for degenerative

neurological diseases. (C-1) 5-3.63 Discuss the pathophysiology of degenerative neurological diseases. (C-1) 5-3.64 Discuss the assessment findings associated with degenerative neurological diseases. (C-1) 5-3.65 Discuss the management/ treatment plan of degenerative neurological diseases. (C-1) 5-3.66 Define the following: (C-1)

  • a.

    Muscular dystrophy

  • b.

    Multiple sclerosis

  • c.

    Dystonia

  • d.

    Parkinson=s disease

  • e.

    Trigeminal neuralgia

  • f.

    Bell’s palsy

  • g.

    Amyotrophic lateral sclerosis

───────────

────────────────────────────────────────────────────────────────────────────

────────────────────────── United States Department of Transportation National Highway Traffic Safety Administration Paramedic: National Standard Curriculum

2

Document info
Document views321
Page views321
Page last viewedSat Dec 10 09:37:32 UTC 2016
Pages127
Paragraphs9956
Words30108

Comments